Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Dec 2025 and Sep 2026.
- Largest single sale: $14.4M (367,600 shares) of Teva Pharmaceutical Industries Ltd on Sep 18, 2026. Filing
- Last sale before this period: Dec 20, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Guardant Health, Inc. (GH) | Director | Oct 29, 2024 | Sep 22, 2026 |
| Teva Pharmaceutical Industries Ltd (TEVA) | Director | Jan 2, 2018 | Sep 22, 2026 |
Also a director at
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 21, 2026, Guardant Health, Inc.: 264 shares vested. 1 filing: 1
- Sep 18, 2026, Teva Pharmaceutical Industries Ltd: sold 367,600 shares for $14.4M, no plan disclosed (some held indirectly). 1 filing: 1
- Aug 21, 2026, Guardant Health, Inc.: 264 shares vested. 1 filing: 1
- Jul 21, 2026, Guardant Health, Inc.: 264 shares vested. 1 filing: 1
- Jun 21, 2026, Guardant Health, Inc.: 264 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.